Analyze US stock balance sheets in depth
Balance sheet, income, cash flow, DCF, and 50+ financial metrics — in one dashboard. NASDAQ and NYSE.
Why Mupuv?
Deep balance sheet analysis
Quarterly and annual balance sheets, health score, Piotroski F-score, Z-score, and liquidity metrics.
Open the AAPL example →DCF & valuation
Discounted cash flow calculator, reverse DCF, and historical valuation bands.
Read the DCF guide →Stock comparison
Compare stocks in the same sector side by side on balance sheet metrics.
Compare AAPL & MSFT →Guides
DCF and valuation multiples, free cash flow, ROIC/WACC, DuPont, dividends, Piotroski and Altman scores — learn the concepts, then apply them on live data.
Popular stocks
Analysis for these stocks is open to everyone — no sign-up required.
Earnings calendar
Frequently asked questions
What is Mupuv?
Mupuv is a free fundamental analysis tool for US-listed stocks (NASDAQ, NYSE, AMEX). It covers balance sheets, income statements, cash flow, DCF valuation, and 50+ financial metrics.
Is Mupuv free?
Yes. Full analysis of popular stocks (such as Apple, Microsoft, and NVIDIA), stock comparison, and the guides are free without signing up. A free account unlocks analysis for every other US stock, plus personal features like portfolio, budget, watchlist, and price alerts.
Which exchanges and stocks are covered?
Thousands of US-listed stocks, including the NASDAQ-100, S&P 500, and sector/dividend universes. Search by ticker or company name; analysis beyond the popular stocks unlocks with a free account.
Where does the data come from and how often is it updated?
Financial data is sourced from a third-party market data provider. Balance sheet and income statement data update with quarterly reports, while price and market metrics refresh regularly during the day.
Do I need to register?
Not for popular-stock analysis, stock comparison, or the guides. Analysis of other stocks and personalization (watchlist, notes, alerts, portfolio) require a free account.
Does Mupuv provide investment advice?
No. Mupuv is an educational and research tool, not investment advice, portfolio management, or a buy/sell recommendation. Always do your own research before making decisions.
